Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitusJooyeon Hwang, Bong‐Jo Kim, Hye‐Ja Lee et al.|Scientific Reports|2018Cited by 30